Earnings Volatility Watch: 10 Stocks Are Set to Swing More Than 10% This Week

Ten stocks carry implied earnings moves above 10% next week, led by Moderna and AppLovin. Five are tech names hit in Friday's chip rout.

Wall Street ended October with a sell-off in chip stocks.

Intel Corp. (NASDAQ:INTC) lost over 40% of its value in October alone, its worst month since 1974, after weaker-than-expected guidance. More than 10 chip stocks fell by over 20% on the month, with Friday’s sell-off wiping out $1 trillion of market value across the sector.

A new week of earnings kicks off with the focus on tech mega caps. Apple Inc. (NASDAQ:AAPL) reports Nov. 2 after the close, Advanced Micro Devices Inc. (NASDAQ:AMD) on Nov. 3 and Qualcomm Inc. (NASDAQ:QCOM) on Nov. 4, both after the close. AMD and Qualcomm each fell more than 11% on Friday.

Yet, the biggest expected swings are elsewhere. Ten stocks with a market cap of at least $25 billion are priced for moves above 10%, and five of them are tech names that fell between 8.3% and 13.7% on Friday, according to Benzinga Pro data.

An implied move is the percentage swing in either direction that options traders expect right after earnings.

Which Stocks Could Swing The Most This Week?

10. Coupang: 10.03% Implied Move

The South Korea-focused e-commerce company reports Nov. 3 after the close. Analysts expect a loss of 3 cents per share on revenue of $9.70 billion.

Second-quarter revenue of $8.90 billion fell just short of estimates, and the shares dropped 4.6% the next day. Deutsche Bank upgraded the stock to Buy afterward.

Coupang Inc. (NYSE:CPNG) is down 39.7% year to date.

9. Revolution Medicines: 11.98% Implied Move

The RAS-focused cancer drug developer reports Nov. 4 after the close. Consensus calls for a loss of $2.40 per share on revenue of $25.48 million.

On Oct. 15, European regulators’ CHMP recommended authorization for Rasonque in metastatic pancreatic cancer. TD Cowen reiterated Buy with a $250 target on Oct. 21.

Revolution Medicines Inc. (NASDAQ:RVMD) is up 137.6% year to date.

8. Cloudflare: 12.07% Implied Move

The web infrastructure and security company reports Nov. 5 after the close. The Street expects earnings of 34 cents per share, in line with guidance, on revenue of $737.95 million.

The shares rose 5.6% after the second-quarter report. They fell 11.9% on Friday. Bernstein raised its target to $245 on Oct. 29 but kept Market Perform.

Cloudflare Inc. (NYSE:NET) is up 38.6% year to date.

7. Natera: 12.18% Implied Move

The genetic testing company reports Nov. 5 after the close. Analysts model a loss of 29 cents per share on revenue of $704.90 million.

The shares jumped 21.4% after the second-quarter report. On Oct. 27, Natera presented new Signatera data in bladder cancer, and BTIG raised its target to $430.

Natera Inc. (NASDAQ:NTRA) is up 81.1% year to date.

6. Lumentum: 12.55% Implied Move

The optical components maker reports its fiscal first quarter Nov. 5 after the close. Consensus calls for earnings of $4.19 per share on revenue of $1.25 billion.

The shares jumped 17% on Oct. 28 on takeover talk involving Marvell Technology Inc. (NASDAQ:MRVL), according to Benzinga, then fell 11.1% on Friday. Jefferies raised its target to $1,250.

Lumentum Holdings Inc. (NASDAQ:LITE) is up 121.8% year to date.

5. Datadog: 12.81% Implied Move

The cloud monitoring platform reports Nov. 4 before the open. Analysts expect earnings of 65 cents per share, the top of guidance, on revenue of $1.15 billion.

In August, earnings beat estimates, yet the shares fell 19.0%. They closed at $229.29 that day and traded near $229 on Friday.

Datadog Inc. (NASDAQ:DDOG) is up 68.6% year to date.

4. Medline: 13.15% Implied Move

The medical supplies maker, public since December 2025, reports Nov. 4 before the open. The Street expects earnings of 35 cents per share on revenue of $7.72 billion.

The shares fell 12.8% after a second-quarter beat. On Oct. 21, the company announced the exit of Medline-brand beds, with costs up to $220 million, according to Benzinga.

Medline Inc. (NASDAQ:MDLN) is down 24.0% year to date.

3. Coherent: 14.15% Implied Move

The optical networking components maker reports its fiscal first quarter Nov. 4 after the close. Analysts model earnings of $1.97 per share on revenue of $2.31 billion.

The shares fell 8.0% after the last report and 12.7% on Friday. B. Riley lowered its target to $262 on Oct. 30.

Coherent Corp. (NYSE:COHR) is up 12.2% year to date.

2. AppLovin: 14.62% Implied Move

The mobile advertising technology company reports Nov. 4 after the close. Consensus calls for earnings of $4.04 per share on revenue of $2.08 billion.

The shares fell 19.7% after the last report and hit 52-week lows in October, according to Benzinga. UBS and RBC Capital lowered their targets on Oct. 28.

AppLovin Corp. (NASDAQ:APP) is down 65.3% year to date.

1. Moderna: 14.70% Implied Move

The mRNA company reports Nov. 6 before the open. Analysts expect a loss of $1.25 per share on revenue of $885.05 million.

On Oct. 22, Merck and Moderna reported Phase 3 melanoma data showing a 42% lower risk of recurrence or death, and the shares plunged about 15% after a YouTuber disclosed a put position, according to Benzinga. William Blair downgraded the stock on Oct. 27.

Moderna Inc. (NASDAQ:MRNA) is up 652.6% year to date.

Photo: Shutterstock